Livzon Pharmaceutical Group Inc (1513.HK)
Company Info
Highlights
HK$31.84B
HK$2.24
10.91
HK$9.06B
HK$5.94B
HK$21.04 - HK$34.00
HK$26.76
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Livzon Pharmaceutical Group Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Livzon Pharmaceutical Group Inc had a return of 13.47% year-to-date (YTD) and 18.37% in the last 12 months. Over the past 10 years, Livzon Pharmaceutical Group Inc had an annualized return of 8.32%, while the S&P 500 had an annualized return of 11.34%, indicating that Livzon Pharmaceutical Group Inc did not perform as well as the benchmark.
1513.HK
13.47%
-1.53%
3.21%
18.37%
8.10%
8.32%
^GSPC (Benchmark)
25.76%
2.84%
14.58%
31.82%
13.85%
11.34%
Monthly Returns
The table below presents the monthly returns of 1513.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -1.45% | 15.13% | -2.74% | 0.94% | -1.49% | -3.02% | -1.02% | 3.55% | 19.15% | -11.51% | 13.47% | ||
2023 | 1.52% | 2.25% | 1.65% | 2.53% | -1.76% | -3.40% | 5.36% | -6.58% | 3.22% | -9.94% | 1.08% | 3.43% | -1.80% |
2022 | -3.16% | 5.98% | -3.76% | -5.15% | 0.23% | 7.74% | -14.00% | -4.92% | -11.35% | 4.42% | 32.36% | -3.49% | -2.19% |
2021 | -4.49% | -0.70% | 16.32% | 9.50% | 9.23% | 0.28% | -23.40% | -1.88% | -0.52% | -10.14% | -0.78% | 11.76% | -1.41% |
2020 | 11.13% | 2.41% | 3.44% | 20.67% | -9.58% | 30.79% | -7.03% | 2.20% | -4.71% | -3.39% | -10.82% | -1.48% | 29.12% |
2019 | 10.77% | 9.72% | -1.27% | 4.40% | -14.04% | 6.12% | 2.69% | 12.47% | -6.73% | 14.18% | 0.22% | 5.44% | 48.54% |
2018 | 4.70% | -9.37% | 7.94% | -10.13% | -0.62% | -8.10% | -1.73% | -14.21% | -15.14% | -15.43% | 25.05% | -20.04% | -49.13% |
2017 | -1.54% | 5.26% | -2.76% | 7.32% | 6.41% | 5.26% | 3.01% | -0.93% | 6.10% | 17.04% | 5.95% | 10.08% | 79.07% |
2016 | -6.84% | -5.90% | 3.98% | 5.88% | -1.39% | -0.09% | 10.33% | 7.02% | 16.16% | -5.33% | 10.39% | -9.11% | 23.87% |
2015 | -8.55% | -7.62% | 24.25% | 12.68% | 16.96% | -17.02% | -10.49% | 7.24% | 0.00% | 0.00% | -12.88% | 7.03% | 2.74% |
2014 | -8.04% | 21.64% | -17.44% | -6.90% | -0.11% | -1.83% | 13.11% | 2.40% | 9.26% | 8.01% | -9.48% | -9.81% | -5.92% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1513.HK is 55, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Livzon Pharmaceutical Group Inc (1513.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Livzon Pharmaceutical Group Inc provided a 5.74% dividend yield over the last twelve months, with an annual payout of HK$1.48 per share. The company has been increasing its dividends for 3 consecutive years.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | HK$1.48 | HK$1.74 | HK$1.51 | HK$1.51 | HK$1.25 | HK$1.37 | HK$1.89 | HK$0.34 | HK$0.27 | HK$0.06 | HK$0.22 |
Dividend yield | 5.74% | 7.22% | 5.76% | 5.28% | 4.17% | 5.63% | 10.81% | 0.93% | 1.31% | 0.34% | 1.33% |
Monthly Dividends
The table displays the monthly dividend distributions for Livzon Pharmaceutical Group Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.48 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.48 | |
2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.74 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.74 |
2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.51 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.51 |
2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.51 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.51 |
2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.25 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.25 |
2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.37 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.37 |
2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.89 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$1.89 |
2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.34 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.34 |
2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.27 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.27 |
2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 |
2014 | HK$0.22 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.22 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Livzon Pharmaceutical Group Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Livzon Pharmaceutical Group Inc was 59.40%, occurring on Jan 3, 2019. Recovery took 356 trading sessions.
The current Livzon Pharmaceutical Group Inc drawdown is 24.12%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-59.4% | Mar 21, 2018 | 194 | Jan 3, 2019 | 356 | Jun 15, 2020 | 550 |
-48.69% | Jul 16, 2020 | 554 | Oct 12, 2022 | 487 | Oct 7, 2024 | 1041 |
-39.56% | May 27, 2015 | 166 | Jan 22, 2016 | 322 | May 17, 2017 | 488 |
-37.35% | Oct 20, 2014 | 83 | Feb 16, 2015 | 34 | Apr 10, 2015 | 117 |
-32.73% | Feb 18, 2014 | 48 | Apr 28, 2014 | 117 | Oct 17, 2014 | 165 |
Volatility
Volatility Chart
The current Livzon Pharmaceutical Group Inc volatility is 5.30%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Livzon Pharmaceutical Group Inc.
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |